Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Acanthopanax wood slices (刺五加木片) are a health food product and plant-based feedstock derived from the dried stems or roots of *Eleutherococcus senticosus* (commonly known as Siberian Ginseng). Developed by Wusuli River Pharmaceutical, these wood slices are utilized as a raw material for the extraction of bioactive compounds, such as eleutherosides, or as a dietary supplement. The product is positioned within the company's research and development pipeline for its adaptogenic properties, specifically aimed at immune enhancement and anti-fatigue applications. As a plant material feedstock, it serves as the primary source for various traditional Chinese medicine formulations and health-oriented food products produced by the company.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Acanthopanax wood slices.